|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-35S1
|
$75,000
|
$1,500
|
LYNCH, THOMAS
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-35S2
|
$333,000
|
$6,660
|
LYNCH, THOMAS
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-35S3
|
$200,000
|
$4,000
|
LYNCH, THOMAS
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-35S4
|
$150,000
|
$3,000
|
LYNCH, THOMAS
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
5P30CA016359-35
|
$2,522,007
|
$50,440
|
LYNCH, THOMAS
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
1U10CA180826-01
|
$551,500
|
$27,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Wnt Signaling and Secreted Frizzled-Related Proteins
|
ZIA BC 010251
|
$211,597
|
$42,319
|
Rubin, Jeffrey
|
CCR (NCI)
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Partici
|
1U10CA180864-01
|
$542,950
|
$20,361
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-29S1
|
$86,403
|
$3,456
|
NICHOLS, CRAIG
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
VHL tumor suppressor gene and the initiation of renal cell carcinoma
|
5R01CA109860-10
|
$318,644
|
$318,644
|
HSU, TIEN
|
BOSTON MEDICAL CENTER
|
|
Veterans Administration hospitalization database Patient Treatment File and Outpatient Clinic File
|
ZIA CP010126 - 00580
|
$55,416
|
$5,542
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
1U10CA180847-01
|
$587,562
|
$29,378
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
1U10CA180870-01
|
$648,000
|
$16,200
|
SCHILLER, JOAN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
1U10CA180858-01
|
$1,192,600
|
$29,815
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Urologic Oncology Research Training Grant
|
5T32CA082088-15
|
$266,073
|
$39,911
|
SCARDINO, PETER
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Urologic Oncology Branch Consult Core
|
ZID BC 011092
|
$1,773,905
|
$1,064,343
|
Linehan, W. Marston
|
CCR (NCI)
|
|
URINARY BIOMARKERS OF RENAL CELL CARCINOMAS
|
5R01CA141521-04
|
$305,938
|
$305,938
|
MORRISSEY, JEREMIAH
|
WASHINGTON UNIVERSITY
|
|
University of Rochester Cancer Center CCOP Research Base
|
3U10CA037420-29S1
|
$365,619
|
$25,593
|
MORROW, GARY
|
UNIVERSITY OF ROCHESTER
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-07S1
|
$355,196
|
$3,552
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-07
|
$1,535,000
|
$15,350
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-15S1
|
$110,575
|
$1,106
|
CARBONE, MICHELE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-15S2
|
$72,113
|
$721
|
CARBONE, MICHELE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-15S4
|
$150,000
|
$1,500
|
CARBONE, MICHELE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of Hawaii Cancer Center CCSG
|
5P30CA071789-15
|
$1,361,692
|
$13,617
|
CARBONE, MICHELE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of Colorado NTCN Lead Academic Participating Site (LAPS)
|
1U10CA180834-01
|
$768,950
|
$38,448
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$267,157
|
$53,431
|
Fowler, Daniel
|
CCR (NCI)
|
|
UM LAPs- U10 Grant
|
1U10CA180801-01
|
$805,799
|
$40,290
|
ZALUPSKI, MARK
|
UNIVERSITY OF MICHIGAN
|
|
UCDCCC NCTN U10 Program
|
1U10CA180846-01
|
$700,250
|
$17,506
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
TWO HIT GENE MAPPING IN RENAL CELL CARCINOMA
|
1R21CA175979-01A1
|
$126,247
|
$126,247
|
MCKAY, JAMES
|
INTERNATIONAL AGENCY FOR RES ON CANCER
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$358,240
|
$7,165
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Translational Surgical Pathology
|
ZIE SC 000853
|
$212,926
|
$85,170
|
Merino, Maria
|
CCR (NCI)
|
|
Translational Research in Cancer
|
3P30CA056036-15S1
|
$73,216
|
$2,929
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
5P30CA056036-15
|
$2,723,515
|
$108,941
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
3U10CA035415-30S1
|
$346,487
|
$13,859
|
MOWAT, REX
|
TOLEDO COMMUNITY HOSPITAL ONCOLOGY PROG
|
|
Tissue Processing/Sequencing Core
|
ZIC BC 011044
|
$464,075
|
$232,037
|
Vocke, Cathy
|
CCR (NCI)
|
|
Tissue Array Research Program
|
ZIC BC 010923
|
$531,130
|
$26,556
|
Hewitt, Stephen
|
CCR (NCI)
|
|
The von Hippel-Lindau Tumor Suppressor Protein:Roles in Cancer and Oxygen Sensing
|
5R01CA068490-19
|
$283,515
|
$283,515
|
KAELIN, WILLIAM
|
DANA-FARBER CANCER INST
|
|
The targeting of the HIF switch in kidney cancer
|
1R01CA181106-01
|
$521,079
|
$521,079
|
KOH, MEI YEE
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
|
THE ROLE OF LIN28B IN WILMS TUMOR
|
1F31CA186444-01
|
$34,996
|
$34,996
|
YERMALOVICH, ALENA
|
CHILDREN'S HOSPITAL CORPORATION
|
|
The Role of KIR and FcR Genotype in the Efficacy of mAb and IL2 Immunotherapy
|
5R01CA166105-03
|
$328,681
|
$65,736
|
SONDEL, PAUL
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
The Role of IKK and NF-kappaB in Controlling mTOR Signaling and TSC Progression
|
5R00CA149178-04
|
$236,591
|
$59,148
|
DAN, HANCAI
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
The Role of Fgf Signaling in Vertebrate Development
|
ZIA BC 010338
|
$238,893
|
$47,779
|
Lewandoski, Mark
|
CCR (NCI)
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-19S3
|
$21,615
|
$216
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-20S1
|
$75,000
|
$750
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-20S2
|
$50,000
|
$500
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-20S3
|
$77,097
|
$771
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-20
|
$4,686,132
|
$46,861
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The pVHL/Jade-1/beta-catenin axis in renal cancer
|
3R01CA079830-13S1
|
$66,893
|
$66,893
|
COHEN, HERBERT
|
BOSTON MEDICAL CENTER
|
|
The pVHL/Jade-1/beta-catenin axis in renal cancer
|
5R01CA079830-13
|
$310,590
|
$310,590
|
COHEN, HERBERT
|
BOSTON MEDICAL CENTER
|
|
The MB-CCOP at Boston Medical Center
|
3U10CA139519-03S5
|
$110,177
|
$1,102
|
KACHNIC, LISA
|
BOSTON MEDICAL CENTER
|
Total relevant funding to Kidney Disease for this search: $40,404,868
|